Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; ...

Received FDA authorization and recorded first commercial sales of ARC-EX System Secured strategic investment from Ottobock ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the confirmatory Phase 3 ...

New Drug Application (NDA) for LNZ100 for treatment ... today reported financial results for the fourth quarter and full year ended December 31, 2024, and recent corporate highlights. “This year has ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the confirmatory Phase 3 RESTORE-ALS tr ...

FDA Approval of Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended De ...

Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsAdanna Alexander – IRPhillip Chan - ...

Revenues Increased by 51%, Gross Profit Increased by 82% and Net Loss Reduced by 54% for the Year Ended December 31, 2024Rehovot, Israel, March ...

Flat V2O5 prices, China expands VRFB production, AMG finishes Nuremberg plant, and Richmond Vanadium advances mining lease ...

By automating routine tasks and reducing friction, AI-powered IDEs allow developers to spend more time developing. Here’s ...

The Institute of Chartered Accountants of India announced the ICAI CA January Result 2025 on Tuesday, March 4, 2025. Stay connected with Livemint for live updates.